Manufacturer record
: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by (Himachal Pradesh) were declared Not of Standard Quality between April 2026 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin & Potassium Clavulanate Tablets IP | ABT25223Mfg 2025-08 · Exp 2027-01 | The content of Amoxycillin in the sample is less(i.e.49.79% of stated amount) and the content of clavulanic acid in the sample is less (i.e.6.56% of the stated amount) than IP limit. (IP Limit-Not less than 90% and Not more than 120% of stated amount) The content of Clavulanic Acid in the sample is less (i.e 29.38% of stated amount ) than the IP limit (IP limit not less than 80% of sated amount) 2. The sample does not comply with IP requirements for the Dissolution test of Amoxicillin and Clavulanic AcidDissolution | FDAL, MaharashtraState lab | Apr 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.